FANCB and Alzheimer disease: The CP initiator C1q has been found to be up-regulated up to 80-fold in areas of human AD brains showing pathological neurodegeneration (Yasojima et al., 1999), a relevant observation in view of the fact that C1q is known to bind directly Aβ fibrils (fAβ) and neurofibrillary tangles (Rogers et al., 1992; Jiang et al., 1994; Shen et al., 2001; Webster et al., 2001; Veerhuis et al., 2003), underscoring the need for a deeper understanding of the C1q specific role in AD pathology.